Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Dividends Paid - Common (2017 - 2025)

Marimed (MRMD) has disclosed Dividends Paid - Common for 9 consecutive years, with $22000.0 as the latest value for Q4 2025.

  • Quarterly Dividends Paid - Common rose 15.79% to $22000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93500.0 through Dec 2025, up 11.98% year-over-year, with the annual reading at $137000.0 for FY2025, 1.44% down from the prior year.
  • Dividends Paid - Common for Q4 2025 was $22000.0 at Marimed, up from $7500.0 in the prior quarter.
  • The five-year high for Dividends Paid - Common was $1.8 million in Q4 2022, with the low at $6000.0 in Q2 2025.
  • Average Dividends Paid - Common over 5 years is $137250.0, with a median of $46000.0 recorded in 2023.
  • The sharpest move saw Dividends Paid - Common soared 1529.36% in 2022, then plummeted 98.31% in 2023.
  • Over 5 years, Dividends Paid - Common stood at $109000.0 in 2021, then soared by 1529.36% to $1.8 million in 2022, then tumbled by 98.31% to $30000.0 in 2023, then crashed by 36.67% to $19000.0 in 2024, then increased by 15.79% to $22000.0 in 2025.
  • According to Business Quant data, Dividends Paid - Common over the past three periods came in at $22000.0, $7500.0, and $6000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.